Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2026)

PROCEPT BioRobotics has reported Total Current Liabilities over the past 7 years, most recently at $63.6 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 22.23% to $63.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $63.6 million through Mar 2026, up 22.23% year-over-year, with the annual reading at $65.8 million for FY2025, 23.83% up from the prior year.
  • Total Current Liabilities was $63.6 million for Q1 2026 at PROCEPT BioRobotics, down from $65.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $65.8 million in Q4 2025 and troughed at $14.8 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $42.8 million (2024), against an average of $42.7 million.
  • Year-over-year, Total Current Liabilities skyrocketed 120.26% in 2023 and then increased 0.47% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $35.3 million in 2022, then skyrocketed by 30.14% to $45.9 million in 2023, then increased by 15.69% to $53.1 million in 2024, then increased by 23.83% to $65.8 million in 2025, then fell by 3.28% to $63.6 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Total Current Liabilities are $63.6 million (Q1 2026), $65.8 million (Q4 2025), and $53.9 million (Q3 2025).